CLADRIBINE TABLETS (CT) VERSUS OTHER DISEASE-MODIFYING THERAPIES IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) - COST-EFFECTIVENESS ANALYSIS.

被引：0
|
作者：
Zieiba, P. [1 ]
Pawlik, D. [2 ]
Wieczorek, J. [2 ]
Wojcik, R. [2 ]
Kaczor, M. P. [3 ]
机构：
[1] Merck Sp Zoo, Warsaw, Poland
[2] Aestimo Sc, Krakow, MA, Poland
[3] Jagiellonian Univ Med Coll, Krakow, Poland
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND51
引用
收藏
页码：S632 / S632
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF FIRST-LINE DISEASE-MODIFYING THERAPIES (DMTs) FOR RELAPSING-REMITTING MS (RAMS)
    Soini, E. J.
    Joutseno, J.
    Somelahti, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A756 - A756
  • [42] COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON BETA-1A VS. FIRST LINE INJECTABLE DISEASE-MODIFYING THERAPIES FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Ruiz, L.
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Harrington, A.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A723 - A723
  • [43] Cost effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
    Mouallif, Soukaina
    Thomas, Kim
    Adlard, Nicholas
    Cooney, Philip
    Blanchette, Francois
    Patel, Barkha
    Baharnoori, Moogeh
    Bhan, Virender
    Clift, Fraser
    Grima, Daniel
    [J]. NEUROLOGY, 2022, 98 (18)
  • [44] COST EFFECTIVENESS OF OFATUMUMAB IN COMPARISON WITH OTHER DISEASE MODIFYING THERAPIES AND BEST SUPPORTIVE CARE FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CANADA
    Mouallif, S.
    Thomas, K.
    Adlard, N. E.
    Cooney, P.
    Blanchette, F.
    Patel, B. P.
    Baharnoori, M.
    Bhan, V
    Clift, F.
    Grima, D.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S63 - S63
  • [45] COST-CONSEQUENCE ANALYSIS OF OFATUMUMAB IN COMPARISON WITH OTHER DISEASE-MODIFYING THERAPIES AND BEST SUPPORTIVE CARE FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CANADA
    Farhane, F.
    Bhan, V
    Clift, F.
    Baharnoori, M.
    Thomas, K.
    Patel, B. P.
    Blanchette, F.
    Adlard, N. E.
    Vudumula, U.
    Gudala, K.
    Dutta, N.
    Grima, D.
    Mouallif, S.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S55 - S56
  • [46] Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
    Moogeh Baharnoori
    Virender Bhan
    Fraser Clift
    Kimberly Thomas
    Soukaïna Mouallif
    Nicholas Adlard
    Philip Cooney
    François Blanchette
    Barkha P. Patel
    Daniel Grima
    [J]. PharmacoEconomics - Open, 2022, 6 : 859 - 870
  • [47] Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
    Baharnoori, Moogeh
    Bhan, Virender
    Clift, Fraser
    Thomas, Kimberly
    Mouallif, Soukaina
    Adlard, Nicholas
    Cooney, Philip
    Blanchette, Francois
    Patel, Barkha P.
    Grima, Daniel
    [J]. PHARMACOECONOMICS-OPEN, 2022, 6 (06) : 859 - 870
  • [48] Olfactory Dysfunction in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Disease-Modifying Therapies
    Wnuk, Marcin
    Drabik, Leszek
    Marona, Monika
    Szaleniec, Joanna
    Bryll, Amira
    Karcz, Paulina
    Kolasinska, Justyna
    Kolasinska, Monika
    Ziekiewicz, Maciej
    Skladzien, Jacek
    Popiela, Tadeusz
    Slowik, Agnieszka
    [J]. ENT-EAR NOSE & THROAT JOURNAL, 2022, 101 (10) : 640 - 644
  • [49] The Effects of Disease-Modifying Therapies on Oxidative Stress in Patients With Relapsing-Remitting Multiple Sclerosis
    Topic, Aleksandra
    Vasic, Marija
    Markovic, Bojan
    Milinkovic, Neda
    Dincic, Evica
    [J]. CLINICAL NEUROPHARMACOLOGY, 2022, 45 (06) : 157 - 161
  • [50] Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom
    Abdel-mannan, Omar A.
    Manchoon, Celeste
    Rossor, Thomas
    Southin, Justine-Clair
    Tur, Carmen
    Brownlee, Wallace
    Byrne, Susan
    Chitre, Manali
    Coles, Alasdair
    Forsyth, Rob
    Kneen, Rachel
    Mankad, Kshitij
    Ram, Dipak
    West, Siobhan
    Wright, Sukhvir
    Wassmer, Evangeline
    Lim, Ming
    Ciccarelli, Olga
    Hemingway, Cheryl
    Hacohen, Yael
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (04):
12345